The contribution of dietary advanced glycation end‐products and genetic risk in the development of inflammatory bowel disease: a prospective cohort study
Dietary CEL was associated with an increased risk of IBD and CD, but not UC. Further interventional studies are required to support the potential benefit of AGE restriction, especially for individuals at a high genetic risk of CD.
Authors
- Fangyuan Jiang (ORCID: https://orcid.org/0000-0001-5833-4722)
- Wenjing Yang (ORCID: https://orcid.org/0000-0003-1541-1892)
- Yu Zhang (ORCID: https://orcid.org/0000-0002-6488-0591)
- Lingya Yao (ORCID: https://orcid.org/0000-0002-5850-1217)
- Qian Cao (ORCID: https://orcid.org/0000-0001-7938-7532)
- Xianghan Cao
- Yushu Cao
Institutions
- Sir Run Run Shaw Hospital (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1111/apt.18218
- Citations
- 9
- Primary Topic
- Advanced Glycation End Products research
- Type
- article
- Field-Weighted Citation Impact
- 3.43
Funders
- National Key Research and Development Program of China